Smart Needle
•
0 likes•638 views
The document summarizes a presentation for a medical device called the Smart Needle. It describes the Smart Needle as a patented, easy to use device that can safely and accurately deliver injections and record data to help reduce medical complications. It estimates the potential market size at over $1 billion based on the large number of procedures performed annually in Russia and the US. The presentation is seeking $2 million in initial funding to support FDA approval and commercialization efforts.
Report
Share
Report
Share
Recommended
Dakriostream
This document describes a new drainage device called "DACRYOSTREAM" for lacrimal surgery developed by the Ufa Eye Research Institute.
The device aims to significantly reduce recurrence rates after surgical treatment for dacryocystitis. It is a hollow silicone tube implanted with a plastic injector that allows for long-term drainage over a year without needing repeat surgery.
Initial experimental and clinical studies show promising results, with the device being well-tolerated and effective in reducing recurrence in 25 patients. Further histological and commercialization studies are needed, for which the inventors are seeking investment.
Colposcope
The YDJ Colposcope from Microscopesmall.com is specially designed for the gynecologic diagnosis and examination. Visit us online to know more.
Eftek bio start-upvillage
This document summarizes a presentation about Express Oncotest, a home-use breast cancer diagnostic test being developed by EFTEK-BIO LLC. It notes that currently only 10% of breast cancer cases are diagnosed at early stages in Russia. The proposed Express Oncotest uses immobilized antibodies on biopolymeric nanofibers to provide a simple, visual breast cancer diagnostic without laboratory equipment. It has the potential to screen the large number of women over 40 who currently require annual screening. The presentation outlines the market opportunity and growth forecast, R&D and marketing plans to develop the prototype and register the product, and competitive advantages over existing diagnostic methods.
Wide Range AFR Control
A production wide-range air-fuel ratio (AFR) control algorithm was developed for direct injection gasoline engines to minimize emissions. The algorithm uses a hybrid state estimator and time-based controller to account for physical engine effects and sensor dynamics. It estimates control errors using a model that accounts for transport delays and sensor characteristics. A gain-scheduled PI controller then corrects fuel injection to reduce errors. The algorithm also adds perturbations to optimize catalyst efficiency and supports calibration. Testing on a 1998 vehicle met Euro IV emissions standards with low hydrocarbon, carbon monoxide, and nitrogen oxide levels.
Lower final exam[1]
Sophia Edwards and her daughter Lina are classmates at Chester College. They both study French and History. Lina thinks it is great that her mother is one of her classmates. In the evenings, Sophia and Lina do their homework together and Sophia cooks dinner while Lina does the washing up. Sophia enjoys being a student again after many years away from school.
Pneumatic State Estimator
The document describes pneumatic and thermal state estimator algorithms developed for a production engine control system. The algorithms estimate engine mass flow, pressure, and temperature to provide inputs for other control and diagnostic functions. A fluid network architecture was used to significantly reduce development time and increase flexibility. The algorithms estimate states like intake manifold pressure and temperature. They provide benefits like automated calibration, flexibility to hardware changes, and compatibility with modern control design approaches.
2010 LMME Presentation
A recent presentation on Social Media for museum educators; just a quick introduction, not a comprehensive review.
Avanquest Overview
Avanquest is the 4th largest consumer software company in the world. It sells 25 million software units annually through major retailers in the US, Canada, and globally. Avanquest owns several #1 brands for educational software, home design software, Mac utilities, and other categories. It has a global network of publishing groups and sales offices covering North America, Europe, Asia, Latin America, Africa, and other regions.
Recommended
Dakriostream
This document describes a new drainage device called "DACRYOSTREAM" for lacrimal surgery developed by the Ufa Eye Research Institute.
The device aims to significantly reduce recurrence rates after surgical treatment for dacryocystitis. It is a hollow silicone tube implanted with a plastic injector that allows for long-term drainage over a year without needing repeat surgery.
Initial experimental and clinical studies show promising results, with the device being well-tolerated and effective in reducing recurrence in 25 patients. Further histological and commercialization studies are needed, for which the inventors are seeking investment.
Colposcope
The YDJ Colposcope from Microscopesmall.com is specially designed for the gynecologic diagnosis and examination. Visit us online to know more.
Eftek bio start-upvillage
This document summarizes a presentation about Express Oncotest, a home-use breast cancer diagnostic test being developed by EFTEK-BIO LLC. It notes that currently only 10% of breast cancer cases are diagnosed at early stages in Russia. The proposed Express Oncotest uses immobilized antibodies on biopolymeric nanofibers to provide a simple, visual breast cancer diagnostic without laboratory equipment. It has the potential to screen the large number of women over 40 who currently require annual screening. The presentation outlines the market opportunity and growth forecast, R&D and marketing plans to develop the prototype and register the product, and competitive advantages over existing diagnostic methods.
Wide Range AFR Control
A production wide-range air-fuel ratio (AFR) control algorithm was developed for direct injection gasoline engines to minimize emissions. The algorithm uses a hybrid state estimator and time-based controller to account for physical engine effects and sensor dynamics. It estimates control errors using a model that accounts for transport delays and sensor characteristics. A gain-scheduled PI controller then corrects fuel injection to reduce errors. The algorithm also adds perturbations to optimize catalyst efficiency and supports calibration. Testing on a 1998 vehicle met Euro IV emissions standards with low hydrocarbon, carbon monoxide, and nitrogen oxide levels.
Lower final exam[1]
Sophia Edwards and her daughter Lina are classmates at Chester College. They both study French and History. Lina thinks it is great that her mother is one of her classmates. In the evenings, Sophia and Lina do their homework together and Sophia cooks dinner while Lina does the washing up. Sophia enjoys being a student again after many years away from school.
Pneumatic State Estimator
The document describes pneumatic and thermal state estimator algorithms developed for a production engine control system. The algorithms estimate engine mass flow, pressure, and temperature to provide inputs for other control and diagnostic functions. A fluid network architecture was used to significantly reduce development time and increase flexibility. The algorithms estimate states like intake manifold pressure and temperature. They provide benefits like automated calibration, flexibility to hardware changes, and compatibility with modern control design approaches.
2010 LMME Presentation
A recent presentation on Social Media for museum educators; just a quick introduction, not a comprehensive review.
Avanquest Overview
Avanquest is the 4th largest consumer software company in the world. It sells 25 million software units annually through major retailers in the US, Canada, and globally. Avanquest owns several #1 brands for educational software, home design software, Mac utilities, and other categories. It has a global network of publishing groups and sales offices covering North America, Europe, Asia, Latin America, Africa, and other regions.
Mobile rheocardiomonitor st.ed.1
The document describes a mobile device called the RheoCardioMonitor that non-invasively monitors cardiac function through ECG and ICG signals. It analyzes the data in real-time. The author is seeking partners for clinical trials of a prototype to obtain certification. Sales are projected to be 15 devices in 2014, growing to 320 devices in 2017 as the technology adds channels, functionality and algorithms. Competitors provide less mobility, require a physician for measurement, or cost more. The author and advisors have expertise in relevant areas and are seeking partners for production, support, and sales to commercialize the technology.
Med Byte
The document proposes a non-invasive home medical device called "Home Doctor" that uses termopuncture diagnostics and treatment via mobile phone. It aims to help patients with chronic illnesses monitor their condition at home without frequent doctor visits. The device allows diagnosis and treatment within minutes by analyzing organ biorhythms. It has advantages over competitors by providing accurate, quantitative health readings without medical expertise. The presentation outlines the device's technology, market potential, business model and management team to attract investors for product completion and market entry.
Neurovascular/Interventional Neurology Market [Aneurysm Coils, Carotid Stents...
This document provides an overview and market analysis of the neurointerventional devices market from 2010 to 2017. It states that the global market was estimated at $1.25 billion in 2012 and is expected to grow at a 6.8% compound annual growth rate to $1.73 billion by 2017. The largest segment is aneurysm coiling and arteriovenous malformation embolization and fistula embolization. North America currently dominates the market but Asia-Pacific and Latin America are expected to grow faster due to increasing healthcare spending. The report covers market drivers, trends, competitive landscape and company profiles of major players.
Start up village intro-micro
Intro-Micro L.L.C. is developing a pocket-sized gas analyzer using patented Collisional Electron Spectroscopy (CES) that can non-invasively monitor human metabolism through detection of volatile biomarker molecules. They seek $0.3M for proof of concept and $2M for a commercial prototype to develop continuous, non-invasive medical diagnostics. Their CES-based analyzer would be cheaper and smaller than competitors, allowing preventative healthcare through mobile monitoring of an individual's unique "gasprint." The founding team has expertise in relevant areas such as electronics, medicine, plasma simulation, and business development.
I bolit-public-eng
1) i-Bolit is developing a mobile diagnostic device (MDD) for the Russian healthcare market, which is projected to grow to $1 billion by 2020.
2) The MDD will use patented wireless communication and sensor technologies to provide diagnostic abilities through an intelligent analytical system.
3) It will have competitive advantages over other devices through its communication protocols, data-driven analytical system, and patented sensor technologies.
The document provides an overview of i-Bolit's proposed mobile diagnostic device, including its technical capabilities, competitive advantages, business model, team, partners, and roadmap.
Mobile rheocardiomonitor [sv ed.]
The document describes a mobile device called the RheoCardioMonitor that can monitor cardiac function through ECG and ICG sensors. It provides non-invasive long-term monitoring with high accuracy at a lower price than competitors. The author is seeking partners for clinical trials and production to license the prototype device which analyzes cardiac data in real-time. Future prospects include adding more sensors and new algorithms.
презентация бельская л.в.
The document proposes a new non-invasive and painless method of diagnosing diseases like cardiovascular disease and diabetes using the composition and mineralization of human saliva. The method was developed by Dr. Belskaya and has 7 invention patents. It has the advantages of early detection, simplicity, and low cost. The business plan involves commercializing the technology through partnerships with public health facilities, commercial labs, insurance companies, and individuals. An investment of $250,000 is requested to enter the estimated $19 million per year Russian diagnostics market.
Test-Lab
The document proposes a non-invasive and painless saliva-based screening methodology to diagnose cardiovascular disease, diabetes, and cancers. It has the advantages of early detection, identification of susceptibility to multiple diseases, and simplicity without expensive equipment. The methodology could be marketed to public health facilities, commercial labs, insurance companies, and individuals. Investors are sought to help commercialize the technology and establish an IVD laboratory, with projected annual profits of $8.5 million serving a potential market of over 3 million customers in Russia.
IoT Based Medical Health Care Chain System
IoT Based Medical Health Care Chain System
Presented in Arya Ideathon 2021
Organized by Arya Group of Colleges, Arya Main Campus Jaipur
Presented by- Aditya Koyande, Gouri Khot, Deepali Khot,
Guruprasad Bhogate
Guided by- Prof. Vaibhav V. Mainkar
Instituite- Sindhudurg Shikshan Prasarak Mandal's College of Engineering, Knakavli
Department of Electronics and telecommunication Engineering
Key Healthcare Takeaways from GTC in October
Three NVIDIA GTC conferences held in Europe, Israel, and Washington D.C. saw record-breaking attendance and brought together healthcare leaders to discuss medical innovations using AI. Key announcements included King's College London adopting NVIDIA's AI platform for radiology and pathology, Oxford Nanopore's real-time DNA sequencing powered by NVIDIA, and a new partnership between NVIDIA and Scripps Research to accelerate disease prediction using genomics and health sensors. Startups in areas like 3D medical printing, eye disease prevention, and assisting pathologists were recognized at the events.
NAPOLY LLC
NAPOLY LLC was founded in 2014 in Russia to develop, manufacture, and sell innovative wound dressings and plasters. Their flagship product, ChitoPran®, is a wound dressing made of chitosan nanofibers that promotes wound healing without needing removal. It has received Russian registration and patent and is manufactured in Russia with an annual production capacity of 30 million units. NAPOLY aims to supply ChitoPran® to medical facilities and pharmacies across Russia and through their online store.
07 гамма локатор
This investment proposal outlines the development of an innovative diagnostic device called Ray-D for detecting cancer tumors and metastases. Ray-D uses radiopharmaceuticals and detection of their emission to accurately determine the spread of tumors, including detecting lymph nodes affected by metastases, without invasive surgery. It has advantages over existing diagnostic methods in terms of accuracy, risk, and health impacts. Ray-D shows potential for diagnosis without surgery, determining tumor borders during operations, and filling an $31.6 billion market. The proposal requests 22 million rubles for R&D, trials, production preparation, and sales launch. It projects a positive NPV, MIRR, and payback period, with 20% investor share in the company.
Neurosurgical Products Market - Global Study on Neurosurgical Products to 2022
Neurosurgical Products Market - Global Study on Neurosurgical Products to 2022Persistence Market Research Pvt. Ltd
The document discusses the global neurosurgical products market. It states that the market is expected to grow from $3.7 billion in 2015 to $7.8 billion by 2022 due to factors like the aging population and rising incidence of brain tumors. Asia Pacific is projected to be the fastest growing region during this period. The top companies in this market include Integra LifeSciences, Stryker, and Medtronic. The report provides a detailed analysis of the market size and growth forecasts by product, condition, procedure, and geographic region.Minimally invasive medical robotics, imaging & visualization systems & surgic...
The MIS market is expected to grow at a fast rate with a CAGR of 8.2% and is expected to reach $35.5 billion by 2016. The surgical instruments segment commanded the larger share; i.e. 38.4%, of the global minimally invasive surgical devices market in 2011. This growth has been primarily attributed to the increased usage of these devices and instruments in MIS procedures. Devices such as guiding catheters and guidewires as well as balloons have been widely used in interventional angioplasty and peripheral extremity MIS procedures. Numerous innovations in the technologies of devices such as balloons have added to the growth in the market.
A Journey from Patient Needs to Health Solutions
Copyright - Jackie Oldham, Manchester Integrated Medicine and Innovative Technologies, University of Manchester, 2011
IPRoduct: Linking Products to Patents
Presentation prepared for the AESIS webinar on “Measuring the Innovation Output of Science” in the series "Big Data Patterns & Signals for Science" More information at: http://aesisnet.com/event/webinar1017clar/
астмедком Public-eng
This document describes a proposed mobile diagnostic device (MDD) created by AstMedKom. The MDD aims to reduce healthcare costs and mortality from chronic diseases by integrating various diagnostic sensors, modules, and telemedicine capabilities into a single portable device. It can diagnose 68 common diseases across multiple body systems using 10 diagnostic methods. The MDD connects to the cloud for data storage and sharing with doctors and patients. It has a modular design and uses low-cost components. The developers project revenue of over 24 million rubles by the fifth year as production scales up, with a payback period of 5 years.
Craniocerebral Therapeutic Hypothermia
The document discusses craniocerebral hypothermia as a treatment for brain injury and overheating. It proposes a solution using a device called "THE-01" to cool just the brain rather than the whole body. The device is presented as having advantages over existing whole-body cooling methods such as fewer complications and not requiring sedation. Clinical use of THE-01 is said to have positive effects. The technology, market potential, and intellectual property of the solution are then outlined.
WELCOME & RETINAL INNOVATION HIGHLIGHTS
Welcome & Innovation Highlights at OIS@ASRS 2016.
Participant:
Emmett T. Cunningham Jr., MD, PhD, MPH, Partner – Clarus
Powered by:
Healthegy
For more ophthalmology innovation
Visit us at www.ois.net
Amnis Theraputics Corporate Presentation
Powerful Medical Branding for Your Medical Device Investor Deck. Example: Amnis Therapeutics Investor Deck by Berliner Design (www.berlinerdesign.co.il).
Cell Therapy Expansion and Challenges in Autoimmune Disease
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
More Related Content
Similar to Smart Needle
Mobile rheocardiomonitor st.ed.1
The document describes a mobile device called the RheoCardioMonitor that non-invasively monitors cardiac function through ECG and ICG signals. It analyzes the data in real-time. The author is seeking partners for clinical trials of a prototype to obtain certification. Sales are projected to be 15 devices in 2014, growing to 320 devices in 2017 as the technology adds channels, functionality and algorithms. Competitors provide less mobility, require a physician for measurement, or cost more. The author and advisors have expertise in relevant areas and are seeking partners for production, support, and sales to commercialize the technology.
Med Byte
The document proposes a non-invasive home medical device called "Home Doctor" that uses termopuncture diagnostics and treatment via mobile phone. It aims to help patients with chronic illnesses monitor their condition at home without frequent doctor visits. The device allows diagnosis and treatment within minutes by analyzing organ biorhythms. It has advantages over competitors by providing accurate, quantitative health readings without medical expertise. The presentation outlines the device's technology, market potential, business model and management team to attract investors for product completion and market entry.
Neurovascular/Interventional Neurology Market [Aneurysm Coils, Carotid Stents...
This document provides an overview and market analysis of the neurointerventional devices market from 2010 to 2017. It states that the global market was estimated at $1.25 billion in 2012 and is expected to grow at a 6.8% compound annual growth rate to $1.73 billion by 2017. The largest segment is aneurysm coiling and arteriovenous malformation embolization and fistula embolization. North America currently dominates the market but Asia-Pacific and Latin America are expected to grow faster due to increasing healthcare spending. The report covers market drivers, trends, competitive landscape and company profiles of major players.
Start up village intro-micro
Intro-Micro L.L.C. is developing a pocket-sized gas analyzer using patented Collisional Electron Spectroscopy (CES) that can non-invasively monitor human metabolism through detection of volatile biomarker molecules. They seek $0.3M for proof of concept and $2M for a commercial prototype to develop continuous, non-invasive medical diagnostics. Their CES-based analyzer would be cheaper and smaller than competitors, allowing preventative healthcare through mobile monitoring of an individual's unique "gasprint." The founding team has expertise in relevant areas such as electronics, medicine, plasma simulation, and business development.
I bolit-public-eng
1) i-Bolit is developing a mobile diagnostic device (MDD) for the Russian healthcare market, which is projected to grow to $1 billion by 2020.
2) The MDD will use patented wireless communication and sensor technologies to provide diagnostic abilities through an intelligent analytical system.
3) It will have competitive advantages over other devices through its communication protocols, data-driven analytical system, and patented sensor technologies.
The document provides an overview of i-Bolit's proposed mobile diagnostic device, including its technical capabilities, competitive advantages, business model, team, partners, and roadmap.
Mobile rheocardiomonitor [sv ed.]
The document describes a mobile device called the RheoCardioMonitor that can monitor cardiac function through ECG and ICG sensors. It provides non-invasive long-term monitoring with high accuracy at a lower price than competitors. The author is seeking partners for clinical trials and production to license the prototype device which analyzes cardiac data in real-time. Future prospects include adding more sensors and new algorithms.
презентация бельская л.в.
The document proposes a new non-invasive and painless method of diagnosing diseases like cardiovascular disease and diabetes using the composition and mineralization of human saliva. The method was developed by Dr. Belskaya and has 7 invention patents. It has the advantages of early detection, simplicity, and low cost. The business plan involves commercializing the technology through partnerships with public health facilities, commercial labs, insurance companies, and individuals. An investment of $250,000 is requested to enter the estimated $19 million per year Russian diagnostics market.
Test-Lab
The document proposes a non-invasive and painless saliva-based screening methodology to diagnose cardiovascular disease, diabetes, and cancers. It has the advantages of early detection, identification of susceptibility to multiple diseases, and simplicity without expensive equipment. The methodology could be marketed to public health facilities, commercial labs, insurance companies, and individuals. Investors are sought to help commercialize the technology and establish an IVD laboratory, with projected annual profits of $8.5 million serving a potential market of over 3 million customers in Russia.
IoT Based Medical Health Care Chain System
IoT Based Medical Health Care Chain System
Presented in Arya Ideathon 2021
Organized by Arya Group of Colleges, Arya Main Campus Jaipur
Presented by- Aditya Koyande, Gouri Khot, Deepali Khot,
Guruprasad Bhogate
Guided by- Prof. Vaibhav V. Mainkar
Instituite- Sindhudurg Shikshan Prasarak Mandal's College of Engineering, Knakavli
Department of Electronics and telecommunication Engineering
Key Healthcare Takeaways from GTC in October
Three NVIDIA GTC conferences held in Europe, Israel, and Washington D.C. saw record-breaking attendance and brought together healthcare leaders to discuss medical innovations using AI. Key announcements included King's College London adopting NVIDIA's AI platform for radiology and pathology, Oxford Nanopore's real-time DNA sequencing powered by NVIDIA, and a new partnership between NVIDIA and Scripps Research to accelerate disease prediction using genomics and health sensors. Startups in areas like 3D medical printing, eye disease prevention, and assisting pathologists were recognized at the events.
NAPOLY LLC
NAPOLY LLC was founded in 2014 in Russia to develop, manufacture, and sell innovative wound dressings and plasters. Their flagship product, ChitoPran®, is a wound dressing made of chitosan nanofibers that promotes wound healing without needing removal. It has received Russian registration and patent and is manufactured in Russia with an annual production capacity of 30 million units. NAPOLY aims to supply ChitoPran® to medical facilities and pharmacies across Russia and through their online store.
07 гамма локатор
This investment proposal outlines the development of an innovative diagnostic device called Ray-D for detecting cancer tumors and metastases. Ray-D uses radiopharmaceuticals and detection of their emission to accurately determine the spread of tumors, including detecting lymph nodes affected by metastases, without invasive surgery. It has advantages over existing diagnostic methods in terms of accuracy, risk, and health impacts. Ray-D shows potential for diagnosis without surgery, determining tumor borders during operations, and filling an $31.6 billion market. The proposal requests 22 million rubles for R&D, trials, production preparation, and sales launch. It projects a positive NPV, MIRR, and payback period, with 20% investor share in the company.
Neurosurgical Products Market - Global Study on Neurosurgical Products to 2022
Neurosurgical Products Market - Global Study on Neurosurgical Products to 2022Persistence Market Research Pvt. Ltd
The document discusses the global neurosurgical products market. It states that the market is expected to grow from $3.7 billion in 2015 to $7.8 billion by 2022 due to factors like the aging population and rising incidence of brain tumors. Asia Pacific is projected to be the fastest growing region during this period. The top companies in this market include Integra LifeSciences, Stryker, and Medtronic. The report provides a detailed analysis of the market size and growth forecasts by product, condition, procedure, and geographic region.Minimally invasive medical robotics, imaging & visualization systems & surgic...
The MIS market is expected to grow at a fast rate with a CAGR of 8.2% and is expected to reach $35.5 billion by 2016. The surgical instruments segment commanded the larger share; i.e. 38.4%, of the global minimally invasive surgical devices market in 2011. This growth has been primarily attributed to the increased usage of these devices and instruments in MIS procedures. Devices such as guiding catheters and guidewires as well as balloons have been widely used in interventional angioplasty and peripheral extremity MIS procedures. Numerous innovations in the technologies of devices such as balloons have added to the growth in the market.
A Journey from Patient Needs to Health Solutions
Copyright - Jackie Oldham, Manchester Integrated Medicine and Innovative Technologies, University of Manchester, 2011
IPRoduct: Linking Products to Patents
Presentation prepared for the AESIS webinar on “Measuring the Innovation Output of Science” in the series "Big Data Patterns & Signals for Science" More information at: http://aesisnet.com/event/webinar1017clar/
астмедком Public-eng
This document describes a proposed mobile diagnostic device (MDD) created by AstMedKom. The MDD aims to reduce healthcare costs and mortality from chronic diseases by integrating various diagnostic sensors, modules, and telemedicine capabilities into a single portable device. It can diagnose 68 common diseases across multiple body systems using 10 diagnostic methods. The MDD connects to the cloud for data storage and sharing with doctors and patients. It has a modular design and uses low-cost components. The developers project revenue of over 24 million rubles by the fifth year as production scales up, with a payback period of 5 years.
Craniocerebral Therapeutic Hypothermia
The document discusses craniocerebral hypothermia as a treatment for brain injury and overheating. It proposes a solution using a device called "THE-01" to cool just the brain rather than the whole body. The device is presented as having advantages over existing whole-body cooling methods such as fewer complications and not requiring sedation. Clinical use of THE-01 is said to have positive effects. The technology, market potential, and intellectual property of the solution are then outlined.
WELCOME & RETINAL INNOVATION HIGHLIGHTS
Welcome & Innovation Highlights at OIS@ASRS 2016.
Participant:
Emmett T. Cunningham Jr., MD, PhD, MPH, Partner – Clarus
Powered by:
Healthegy
For more ophthalmology innovation
Visit us at www.ois.net
Amnis Theraputics Corporate Presentation
Powerful Medical Branding for Your Medical Device Investor Deck. Example: Amnis Therapeutics Investor Deck by Berliner Design (www.berlinerdesign.co.il).
Similar to Smart Needle (20)
Neurovascular/Interventional Neurology Market [Aneurysm Coils, Carotid Stents...
Neurovascular/Interventional Neurology Market [Aneurysm Coils, Carotid Stents...
Neurosurgical Products Market - Global Study on Neurosurgical Products to 2022
Neurosurgical Products Market - Global Study on Neurosurgical Products to 2022
Minimally invasive medical robotics, imaging & visualization systems & surgic...
Minimally invasive medical robotics, imaging & visualization systems & surgic...
Recently uploaded
Cell Therapy Expansion and Challenges in Autoimmune Disease
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Kosmoderma Academy Of Aesthetic Medicine
Kosmoderma Academy, a leading institution in the field of dermatology and aesthetics, offers comprehensive courses in cosmetology and trichology. Our specialized courses on PRP (Hair), DR+Growth Factor, GFC, and Qr678 are designed to equip practitioners with advanced skills and knowledge to excel in hair restoration and growth treatments.
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
10 Benefits an EPCR Software should Bring to EMS Organizations
The benefits of an ePCR solution should extend to the whole EMS organization, not just certain groups of people or certain departments. It should provide more than just a form for entering and a database for storing information. It should also include a workflow of how information is communicated, used and stored across the entire organization.
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
This document outlines policies and procedures for handling narcotic and controlled drugs in NABH accredited hospitals.
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Efficacy of Avartana Sneha in Ayurveda
Avartana Sneha is a unique method of Preparation of Sneha Kalpana in Ayurveda, mainly it is indicated for the Vataja rogas.
Acute Gout Care & Urate Lowering Therapy .pdf
In this document , the management of acute gout attacks and a description of urate lowering therapy is mentioned.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
The Nervous and Chemical Regulation of Respiration
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Histololgy of Female Reproductive System.pptx
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Ketone bodies and metabolism-biochemistry
This slide consists of all the topics of ketone . This can be used for exam purpose for writing about Diabetic keto acidosis etc . Thank you
Recently uploaded (20)
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Smart Needle
- 1. Dmitry Shpakov Igloptika Ltd. tel . : +7 ( 911 ) 990-90-66 Skype: igloptika igloptika @mail.ru « Smart Needle » «Injection s must be safe !»
- 3. Pain C hildbirth anesthesia Russia USA Loss from one complication $2,3K $ 85 K Number of operations, annual 1,5 M 3 ,2M Complications rate 1% Number of Complications 15 000 32 000 Loss $34, 5 M $ 2,72 B
- 9. Business-model OEMs Smart Needle USA Production , marketing , sales, support Insurance companies Physicians Hospitals , cliniks SN – Smart Needle . Igloptika, Ltd. R&D Distributors $ SN SN SN SN Marketing $ $ Feed-back Feed-back
- 11. Team Dmitry Shpakov – CEO Designing of optical devices (6 years), executive management. Svjatoslav Latyev – CTO PhD, Professor, Chief designer Vladimir Volchkov – Med Adviser PhD, Professor, Chief Anesthesiologist of North-West region of Russia Sergey Poduzov – Biz Adviser MIBA, 6 years in corporate finance Michael Shpakov - CIO PhD, 16 years in software development
- 12. Current status & Roadmap Prototype 2009 Testing prototype 2009 P re-production model 2010 PCT Patent 2010 FDA Approval 201 1-2013 Today Sertification in Russia 2011 1-st Round 2-nd Round